Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00470
|
|||||
| Drug Name |
Amitriptyline
|
|||||
| Synonyms |
10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene; 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(5),gamma-propylamine; 10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene; 3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)-N,N-dimethylpropylamin; 3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine; 5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene; 5-(3'-Dimethylaminopropylidene)-dibenzo-[a,d][1,4]-cycloheptadiene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene; 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(3-Dimethylaminopropylidene)-5H-dibenzo[a,d]-10,11-dihydrocycloheptene; 5-(3-dimethylaminopropylidene)dibenzo[a,d][1,4]-cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene; 5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptadiene; 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,d]10,11-dihydrocycloheptene; 5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene; Adepress; Adepril; Amitril; Amitriprolidine; Amitriptilina; Amitriptilina [INN-Spanish]; Amitriptilina [Italian]; Amitriptylin; Amitriptylin [German]; Amitriptyline (INN); Amitriptyline [INN:BAN]; Amitriptylinum; Amitriptylinum [INN-Latin]; Amitryptiline; Amitryptyline; Amytriptiline; Amytriptylin; Damilan; Damilen; Damitriptyline; Elanil; Elavil; Elavil (TN); Flavyl; Lantron; Laroxil; Laroxyl; Laroxyl (TN); MK 230; N 750; Proheptadiene; Redomex; Ro 4-1575; Sarotex; Seroten; Sylvemid; TP0; Triptanol; Triptilin; Triptisol; Tryptanol; [3-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidene)-propyl]-dimethyl-amine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Major depressive disorder [ICD11: 6A70.3] | Approved | [1] | |||
| Therapeutic Class |
Analgesics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H23N
|
|||||
| Canonical SMILES |
CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
|
|||||
| InChI |
InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3
|
|||||
| InChIKey |
KRMDCWKBEZIMAB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 50-48-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 277.4 | Topological Polar Surface Area | 3.2 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 1 | |||
| XLogP |
5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10524415
, 10589138
, 11110782
, 11110783
, 11335941
, 11361180
, 11362838
, 11364675
, 11365400
, 11367237
, 11367962
, 11369799
, 11371436
, 11372840
, 11373731
, 11375399
, 11376124
, 11377962
, 11462152
, 11466102
, 11467222
, 11483818
, 11485944
, 11487917
, 11490114
, 11491961
, 11493858
, 11534105
, 14775196
, 29221339
, 4426037
, 46508798
, 47291168
, 47440289
, 47440290
, 47589029
, 47662314
, 47662315
, 47662316
, 47736512
, 48035153
, 48185028
, 48334525
, 48334526
, 48415554
, 597372
, 7978691
, 8151468
, 841048
, 9042
|
|||||
| ChEBI ID |
ChEBI:2666
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Amitriptyline was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. Int J Pharm. 2003 Sep 16;263(1-2):113-22. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.